Frequency of Electrolytes Abnormalities in Cirrhotic Patients Presenting with Hepatic Encepahlopathy
DOI:
https://doi.org/10.70749/ijbr.v3i6.1700Keywords:
Hepatic Encephalopathy, Cirrhosis, Hyponatremia, Hypokalemia, Electrolyte Abnormalities, Liver DiseaseAbstract
Background: Hepatic encephalopathy (HE) is a serious complication of liver cirrhosis, characterized by neuropsychiatric impairments that significantly impact patient morbidity and mortality. Electrolyte abnormalities, particularly hyponatremia and hypokalemia, are common in cirrhotic patients and are known to exacerbate HE. This study aims to determine the frequency of electrolyte abnormalities in cirrhotic patients presenting with HE and their association with clinical variables. Methods: A descriptive cross-sectional study was conducted over six months at the Department of Medicine, Khyber Teaching Hospital, Peshawar. A total of 60 cirrhotic patients with HE, aged 20–70 years, were included using non-probability sampling. Serum sodium and potassium levels were measured to identify hyponatremia (<125 mmol/L) and hypokalemia (<3.5 mmol/L). Data were analyzed using SPSS version 20, with mean and standard deviation calculated for numerical variables and frequencies and percentages for categorical variables. Stratification was performed based on age, gender, and grades of hepatic encephalopathy, with statistical significance assessed using the chi-square test (p < 0.05). Results: The study found a high prevalence of electrolyte abnormalities, with hyponatremia observed in 75% of patients and hypokalemia in 50%. Both abnormalities were present in 33.3% of cases. Patients aged 41–50 showed the highest abnormalities prevalence (86.7%), followed by the 51–60 age group (76.9%). Stratification by hepatic encephalopathy grade revealed that Grades III and IV were associated with significantly higher rates of electrolyte disturbances (86.7% and 80%, respectively; p < 0.01). Gender was not significantly associated with electrolyte abnormalities (p > 0.05). Conclusion: Electrolyte abnormalities, particularly hyponatremia and hypokalemia, are highly prevalent in cirrhotic patients with hepatic encephalopathy, especially in middle-aged individuals and those with advanced disease grades. Early identification and correction of these disturbances are critical to improving clinical outcomes and reducing morbidity in this vulnerable population.
Downloads
References
Younossi ZM, Wong G, Anstee QM, et al. The global burden of liver disease. Clinical Gastroenterology and Hepatology 2023;21(8):1978-91.
https://doi.org/10.1016/j.cgh.2023.04.015
Devarbhavi H, Asrani SK, Arab JP, et al. Global burden of liver disease: 2023 update. Journal of hepatology 2023;79(2):516-37.
https://doi.org/10.1016/j.jhep.2023.03.017
Liu Y-B, Chen M-K. Epidemiology of liver cirrhosis and associated complications: Current knowledge and future directions. World journal of gastroenterology 2022;28(41):5910.
https://doi.org/10.3748/wjg.v28.i41.5910
Tejpal S, Sharma SK, Sharma A, et al. A comprehensive review on hepatic encephalopathy: pathophysiology, symptoms, epidemiology, classification, diagnosis and treatment. J Res Appl Sci Biotechnol 2024;3(3):170-80.
Ochoa-Sanchez R, Tamnanloo F, Rose CF. Hepatic encephalopathy: from metabolic to neurodegenerative. Neurochemical research 2021;46(10):2612-25.
Shaw J, Beyers L, Bajaj JS. Inadequate practices for hepatic encephalopathy management in the inpatient setting. Journal of Hospital Medicine 2022;17:S8-S16.
https://doi.org/10.1002/jhm.12897
Brus TV, Evgrafov VA. Pathophysiology of hepatic insufficiency. Pediatrician (St Petersburg) 2022;13(3):55-64.
Roy A, Dhiman S, Dhiman RK. Hepatic encephalopathy. Hepatology 2025:343-70.
https://doi.org/10.1016/b978-0-443-26710-9.00012-2
García-Martínez R, Diaz-Ruiz R, Poncela M. Management of hepatic encephalopathy associated with advanced liver disease. Clinical Drug Investigation 2022;42(Suppl 1):5-13.
Häussinger D, Butz M, Schnitzler A, et al. Pathomechanisms in hepatic encephalopathy. Biological Chemistry 2021;402(9):1087-102.
Chen A, Tait C, Minacapelli C, et al. Pathophysiology of Hepatic Encephalopathy: A Framework for Clinicians. Clinics in Liver Disease 2024;28(2):209-24.
https://doi.org/10.1016/j.cld.2024.01.002
Kowshik MM, Islam N, Ahmed F, et al. Association between Serum Electrolyte Level and Outcomes among Hospitalized Liver Cirrhosis Patients Presented with Hepatic Encephalopathy Admitted at a Tertiary Care Hospital. Journal of Current and Advance Medical Research 2023;10(1):41-46.
https://doi.org/10.3329/jcamr.v10i1.69970
Khan S, Butt NI, Tareen MQK, et al. Hyponatremia in liver cirrhosis patients presenting with hepatic encephalopathy. The Professional Medical Journal 2022;29(07):970-74.
https://doi.org/10.29309/tpmj/2022.29.07.7057
Ravindranath A, Srivastava A, Yachha SK, et al. Prevalence and Precipitants of Hepatic Encephalopathy in Hospitalized Children With Chronic Liver Disease. Journal of Clinical and Experimental Hepatology 2024;14(6):101452.
https://doi.org/10.1016/j.jceh.2024.101452
Ullah H, Shabana H, Rady MA, et al. Hypokalemia as a responsible factor related with the severity of hepatic encephalopathy: A Wide multination cross-sectional study. Annals of Medicine and Surgery 2023;85(6):2427-31.
https://doi.org/10.1097/ms9.0000000000000470
Suryanarayana M, Michael A, Vellingiri K, et al. Study of creatinine and electrolyte variations amid individuals with chronic liver disease: A retrospective study. J Med Sci Res 2024;12(2):164-68.
https://doi.org/10.17727/jmsr.2024/12-31
Adnan SA, Qasim MI. Hyponatremia and its Clinical Outcome Among Patients with Hepatic Encephalopathy Due to Liver Cirrhosis Present to ATH Abbottabad. Pakistan Journal of Medical & Health Sciences 2023;17(02):357-57.
https://doi.org/10.53350/pjmhs2023172357
Chhabra A, Singh P, Singh G, et al. To measure and correlate the serum sodium levels in chronic liver disease patients with hepatic encephalopathy. 2024
Choudhury BN, Baruah BJ, Gandhi N, et al. A Clinical Study of Dyselectrolytemia in Patients with Cirrhosis of Liver and its Association with Severity of Disease and Development of Complications. J Indian Med Assoc 2023;121(8):00-00.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research

This work is licensed under a Creative Commons Attribution 4.0 International License.